Trade BCTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BriaCell Therapeutics Corp. Common Shares (BCTX) is trading at US$4.21, down 0.24% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$35.41M. Over the past 52 weeks, BCTX has traded between US$2.60 and US$14.68. On Syfe you can trade BCTX with $0 commission and add it to your watchlist.
| Previous close | US$4.22 |
|---|---|
| Market cap | US$35.41M |
| 52-week range | US$2.60 – US$14.68 |
| Volume | 265.51K |
| Exchange | US |
Add to Watchlist
Set Price Alert
BriaCell Therapeutics Corp. Common Shares
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Year: 2023
BriaCell Therapeutics Closes $4.7 Million Share Offering
Jun 2, 8:24 PM · MT Newswires
BriaCell Therapeutics Prices $4.7 Million Share Offering
Jun 1, 7:59 AM · MT Newswires
Stay on top of BCTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
